{"nct_id":"NCT02504372","title":"Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2015-11-06","start_date_type":"ACTUAL","primary_completion_date":"2023-01-24","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-21","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}